These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1373230)

  • 21. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
    Huang CC; Wu MS; Lin DY; Liaw YF
    Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis-C virus antibody conversion in 3 hemodialysis patients in various dialysis departments].
    Schneeberger PM; Hoogenboom-Verdegaal A; van Es A; Schreuder H
    Ned Tijdschr Geneeskd; 1995 Jun; 139(23):1187-90. PubMed ID: 7540730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus associated with Irish anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1994 Mar; 4(9):39. PubMed ID: 7513236
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to hepatitis C virus in thalassemia patients.
    Isahak I; Baharin R; Hakim AS; Abu Bakar M; George E
    Malays J Pathol; 1993 Jun; 15(1):85-7. PubMed ID: 8277796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of antibodies to hepatitis C virus in intravenous drug addicts.
    Verdier D; Boissonnas A; Pouliquen-Nicol A; Christoforov B
    Eur J Med; 1993 Apr; 2(4):253. PubMed ID: 7505162
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of hepatitis C virus antibodies in a hemodialysis unit].
    Rodríguez MI; Estay R; Soto JR; Wolff C; Plubins L; Child R; Armas R
    Rev Med Chil; 1993 Feb; 121(2):152-5. PubMed ID: 7508140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late seroconversion of C virus markers in hemodialysis patients.
    Oliva JA; Maymo RM; Carrio J; Delgado O; Mallafre JM
    Kidney Int Suppl; 1993 Jun; 41():S153-6. PubMed ID: 7686592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Initial results of monitoring hepatitis C virus antibodies in selected population groups in Slovakia. Preliminary results].
    Schwanzerová I; Masár I; Blaskovícová H; Schwanzer V
    Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):60-1. PubMed ID: 1707349
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-HCV antibodies among hemodialysed and kidney-transplanted patients].
    Juszczyk J; Flieger J; Syczewska M; Krzymański M
    Przegl Epidemiol; 1994; 48(1-2):3-9. PubMed ID: 8073139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus and organ transplantation.
    Morales JM; Andrés A; Campistol JM
    N Engl J Med; 1993 Feb; 328(7):511-2; author reply 513. PubMed ID: 7678442
    [No Abstract]   [Full Text] [Related]  

  • 36. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
    Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
    Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus antibody in Kuwait.
    al-Nakib B; Koshy A; Kaloui M; al-Ramahi S; al-Mufti S; Radhakrishnan S; al-Nakib W
    Vox Sang; 1992; 63(1):75-6. PubMed ID: 1384237
    [No Abstract]   [Full Text] [Related]  

  • 38. Home hemodialysis protects against hepatitis C virus transmission.
    Pascual J; Teruel JL; Liaño F; Ortuño J
    Nephron; 1993; 64(2):314. PubMed ID: 7686638
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of antibodies to hepatitis C virus in a population of south eastern France infected with HIV].
    Rosenthal E; Pesce A; Vinti H; Reboulot B; Fuzibet JG; Maiolini R; Cassuto JP
    Presse Med; 1991 Apr; 20(15):710. PubMed ID: 1646450
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to hepatitis C virus in patients on haemodialysis.
    Alonso MC; Novoa D; Romero R; Arcocha V; Sanchez-Guisande D
    Nephron; 1991; 57(2):247. PubMed ID: 1850500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.